2-Benzofurancarboxylic acid, 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-, ethyl ester, hydrochloride (1:2), 98%, 100mg

Tert-butyl(5s)-5-amino-2-oxo-piperidine-1-carboxylate, 98%, 500mg

3-iodo-2,5,6-trimethyl-1,4-dihydropyridin-4-one, 95+%, 100mg

(4-NITRO-2-(TRIFLUOROMETHYL)PHENYL)METHANOL, 95.0%, 5g

Sodium 4-Ethylbenzenesulfonate>98.0%(HPLC)(T)25g

acide valérénique, avec analyt. Documents, 200 mg, emballage en verre

di-tert-Butyl 6,7-dihydro-1H-imidazo[4,5-c]pyridine-1,5(4H)-dicarboxylate, 97%, 100mg

4-Ethyltoluene>97.0%(GC)25mL

2-Amino-1-ethyl-7-(3-hydroxy-4-methoxy-3-methylbut-1-yn-1-yl)-N-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide, 95.0%, 25mg

5-Phenyl-2-(piperidin-4-yl)thiazole, 95.0%, 100mg

5-(4-Methylphenyl)-1,3,4-oxadiazole-2-thiol, 98.0%, 5g

POTASSIUM PHENYL SULFATE, 98%, 250mg

6-Phenylmethoxypyridine-3-carboxylic acid, 95%, 5g